Literature DB >> 23912750

Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS.

Li-Na Wei1, Li-Lin Li, Cong Fang, Rui Huang, Xiao-Yan Liang.   

Abstract

PURPOSE: To explore the effects of controlled ovarian stimulation (COS) on the expression of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) in oocytes and granulosa cells from patients with or without polycystic ovary syndrome (PCOS).
METHODS: This case-control study was conducted in the university affiliated hospital. The study comprised four groups of patients: eighteen PCOS patients with COS (stimulated-PCOS) and twenty-two PCOS patients without COS (unstimulated-PCOS), twenty-nine normal ovulatory women with COS (stimulated-control) and twenty-eight normal ovulatory women without COS (unstimulated-control). The oocytes and granulosa cells were collected and the abundance of GDF9 and BMP15 mRNA in the cells were detected by nested quantitative real-time PCR.
RESULTS: The abundance of GDF9 and BMP15 mRNA was significantly higher both in oocytes (P < 0.01, P < 0.001, respectively) and GCs (P < 0.01, P < 0.05, respectively) from stimulated-control group than in unstimulated-control group. However, there was no significant difference for GDF9 or BMP15 mRNA in oocytes from stimulated-PCOS goup compared with unstimulated-PCOS group (P > 0.05, P > 0.05, respectively). The abundance of GDF9 mRNA was significantly lower (P < 0.01) while the abundance of BMP15 mRNA was significantly higher (P < 0.001) in GCs from stimulated-PCOS group than in unstimulated-PCOS group.
CONCLUSIONS: The controlled ovarian stimulation can promote the expression of GDF9 and BMP15 both in oocytes and GCs from normal ovulatory women. However, the stimulating effects may be inhibited in oocytes from PCOS patients, which subsequently impair cytoplasm maturation and lead to poor oocyte quality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912750      PMCID: PMC3824850          DOI: 10.1007/s10815-013-0041-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  22 in total

Review 1.  Anti-Müllerian hormone and folliculogenesis.

Authors:  Jenny A Visser; Axel P N Themmen
Journal:  Mol Cell Endocrinol       Date:  2005-04-29       Impact factor: 4.102

Review 2.  An oocentric view of folliculogenesis and embryogenesis.

Authors:  Karla J Hutt; David F Albertini
Journal:  Reprod Biomed Online       Date:  2007-06       Impact factor: 3.828

Review 3.  Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality.

Authors:  Robert B Gilchrist; Michelle Lane; Jeremy G Thompson
Journal:  Hum Reprod Update       Date:  2008-01-05       Impact factor: 15.610

4.  Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.

Authors:  C Yan; P Wang; J DeMayo; F J DeMayo; J A Elvin; C Carino; S V Prasad; S S Skinner; B S Dunbar; J L Dube; A J Celeste; M M Matzuk
Journal:  Mol Endocrinol       Date:  2001-06

5.  Oocyte-secreted factors enhance oocyte developmental competence.

Authors:  Tamer S Hussein; Jeremy G Thompson; Robert B Gilchrist
Journal:  Dev Biol       Date:  2006-06-17       Impact factor: 3.582

6.  A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.

Authors:  E M E W Heijnen; M J C Eijkemans; E G Hughes; J S E Laven; N S Macklon; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2005-08-25       Impact factor: 15.610

Review 7.  The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development.

Authors:  J L Juengel; K P McNatty
Journal:  Hum Reprod Update       Date:  2005-02-10       Impact factor: 15.610

8.  Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells.

Authors:  Hsun-Ming Chang; Christian Klausen; Peter C K Leung
Journal:  Fertil Steril       Date:  2013-05-10       Impact factor: 7.329

9.  Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice.

Authors:  Christine X Yeo; Robert B Gilchrist; Jeremy G Thompson; Michelle Lane
Journal:  Hum Reprod       Date:  2007-10-12       Impact factor: 6.918

Review 10.  TGF-beta superfamily members and ovarian follicle development.

Authors:  Phil G Knight; Claire Glister
Journal:  Reproduction       Date:  2006-08       Impact factor: 3.906

View more
  5 in total

1.  Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish.

Authors:  Yi-Lin Yan; Thomas Desvignes; Ruth Bremiller; Catherine Wilson; Danielle Dillon; Samantha High; Bruce Draper; Charles Loren Buck; John Postlethwait
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

2.  Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome.

Authors:  Li-Na Wei; Rui Huang; Li-Lin Li; Cong Fang; Yi Li; Xiao-Yan Liang
Journal:  J Assist Reprod Genet       Date:  2014-08-30       Impact factor: 3.412

3.  N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome.

Authors:  Ebrahim Cheraghi; Malek Soleimani Mehranjani; Seyed Mohammad Ali Shariatzadeh; Mohammad Hossein Nasr Esfahani; Behrang Alani
Journal:  Int J Fertil Steril       Date:  2017-10-12

Review 4.  The role of androgen hormones in early follicular development.

Authors:  Catiele Garcia Gervásio; Marcelo Picinin Bernuci; Marcos Felipe Silva-de-Sá; Ana Carolina Japur de Sá Rosa-E-Silva
Journal:  ISRN Obstet Gynecol       Date:  2014-04-10

5.  GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome.

Authors:  Meryem İlkay Karagül; Savaş Aktaş; Banu Coşkun Yılmaz; Mustafa Yılmaz; Gülhan Orekici Temel
Journal:  Balkan Med J       Date:  2017-09-13       Impact factor: 2.021

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.